| Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis F Lamoth, CJ Clancy, F Tissot, K Squires, P Eggimann, U Flückiger, ... Open forum infectious diseases 7 (3), ofaa075, 2020 | 33 | 2020 |
| Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients EL Heil, KC Claeys, EG Kline, TM Rogers, KM Squires, A Iovleva, Y Doi, ... Journal of Antimicrobial Chemotherapy 78 (4), 1034-1040, 2023 | 6 | 2023 |
| Impact of ompk36 genotype and KPC subtype on the in vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producing … TM Rogers, EG Kline, MP Griffith, CE Jones, AM Rubio, KM Squires, ... JAC-Antimicrobial Resistance 5 (2), dlad022, 2023 | 4 | 2023 |
| Within-host genotypic and phenotypic diversity of contemporaneous carbapenem-resistant Klebsiella pneumoniae from blood cultures of patients with bacteremia S Cheng, G Fleres, L Chen, G Liu, B Hao, A Newbrough, E Driscoll, ... Mbio 13 (6), e02906-22, 2022 | 4 | 2022 |
| 1726. Candida albicans Virulence Genes Induced During Intra-abdominal Candidiasis (IAC) in the Absence of Antifungal Exposure Mediate Echinocandin … CJ Clancy, P Samanta, S Cheng, K Squires, MH Nguyen Open Forum Infectious Diseases 6 (Supplement_2), S633-S633, 2019 | 3 | 2019 |
| In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitors RK Shields, EG Kline, KM Squires, D Van Tyne, Y Doi JAC-Antimicrobial Resistance 5 (5), dlad107, 2023 | 2 | 2023 |
| Sequence type-258 carbapenem-resistant Klebsiella pneumoniae isolates in which ceftazidime–avibactam resistance emerged are not hypermutators KM Squires, MH Nguyen, RK Shields, CJ Clancy Diagnostic Microbiology and Infectious Disease 96 (3), 114954, 2020 | 2 | 2020 |
| Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing … TM Rogers, EG Kline, MP Griffith, CE Jones, AM Rubio, KM Squires, ... JAC-Antimicrobial Resistance 5 (5), dlad113, 2023 | 1 | 2023 |
| Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates KJ Westbrook, GS Chilambi, ME Stellfox, HR Nordstrom, Y Li, A Iovleva, ... Journal of Antimicrobial Chemotherapy, dkae032, 2024 | | 2024 |
| 2183. Porin Mutations Potentiate the in Vitro Synergy of Meropenem-Vaborbactam (MVB), but not Ceftazidime-Avibactam (CZA) in Combination with Other Antibiotics against KPC … TM Rogers, EG Kline, KM Squires, C Jones, RK Shields Open Forum Infectious Diseases 10 (Suppl 2), 2023 | | 2023 |
| 2185. In vitro activity of aztreonam-avibactam (ATM-AVI), cefiderocol (FDC), and cefepime-taniborbactam (FEP-TAN) against multi-species, NDM-producing Enterobacterales causing … EG Kline, KM Squires, G Haidar, G Snyder, L Harrison, D Van Tyne, ... Open Forum Infectious Diseases 10 (Suppl 2), 2023 | | 2023 |
| 1114. Exploring bactericidal activity and emergence of resistance for carbapenem-resistant Enterobacterales (CRE) with and without Klebsiella pneumoniae carbapenemase (KPC … KM Squires, EG Kline, C Jones, RK Shields Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 087, 2023 | | 2023 |
| 2186. Treatment-emergent resistance to ceftazidime-avibactam (CZA) is more common than ceftolozane-tazobactam (CT) among patients infected with multidrug-resistant (MDR … S Shah, G Haidar, KM Squires, EG Kline, JM Pogue, EK McCreary, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1808, 2023 | | 2023 |
| 60 Bacteriophage therapy for Pseudomonas aeruginosa infections in people with cystic fibrosis SE Dorozko, N Wallace, H Nordstrom, K Squires, E Kline, KH Kramer, ... Journal of Cystic Fibrosis 22, S32-S33, 2023 | | 2023 |
| 246. Carbapenem-resistant Klebsiella (CRK) Bloodstream Infections (BSIs) Are Caused by Bacterial Populations That Are Genotypically and Phenotypically Diverse. MH Nguyen, L Chen, S Cheng, K Squires, B Hao, RK Shields, ... Open Forum Infectious Diseases 6, 2019 | | 2019 |
| 2887. Identifying Candida albicans Transcription Factors (TFs) That Regulate Pathogenesis of Intra-abdominal Candidiasis (IAC) by Screening a Deletion Mutant Library. CJ Clancy, S Cheng, K Squires, MH Nguyen Open Forum Infectious Diseases 6, 2019 | | 2019 |
| 357. Aspergillus Isolates Remain Largely Susceptible to Azoles and Other Antifungals at a Large Transplant Program Using Azole Prophylaxis E Driscoll, CJ Clancy, K Squires, RK Shields, MH Nguyen Open Forum Infectious Diseases 5 (Suppl 1), S140, 2018 | | 2018 |
| Examination of Metabolism and Cellular Health in a Saccharomyces cerevisiae Model for TPI Deficiency K Squires, C Barnes, K Koziara, I Fischer, A Lellock, S Hrizo The FASEB Journal 29, 884.27, 2015 | | 2015 |
| Examination of enzyme and metabolic activity in yeast expressing mutant alleles of triose phosphate isomerase (578.1) K Koziara, C Barnes, K Squires, I Fisher, S Hrizo The FASEB Journal 28, 578.1, 2014 | | 2014 |
